We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03534323
Brief Title: Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

First Submitted : May 2, 2018
First Submitted that Met QC Criteria : May 11, 2018
First Posted : May 23, 2018

Last Update Submitted that Met QC Criteria : January 6, 2023
Last Update Posted : January 10, 2023